Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (351-360 of 525) with videos related to

Pageof 53
Sort By:
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Journal of Virology|February 14, 2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman PrimatesKevin O Saunders, Sampa Santra, Robert Parks, et al.
Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope ProteinMina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Journal of Virology|May 10, 2013
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesPinghuang Liu, Nicole L Yates, Xiaoying Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2015
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV InfectionRafael Cubas, Julien van Grevenynghe, Saintedym Wills, et al.
Blood Advances|January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPsJoseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Vaccine|July 7, 2021
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest periodYunda Huang, Kelly E Seaton, Martin Casapia, et al.
Pageof 53

Showing results (351-360 of 525) with videos related to

Sort By:
Pageof 53
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Journal of Virology|February 14, 2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman PrimatesKevin O Saunders, Sampa Santra, Robert Parks, et al.
Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope ProteinMina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Journal of Virology|May 10, 2013
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesPinghuang Liu, Nicole L Yates, Xiaoying Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2015
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV InfectionRafael Cubas, Julien van Grevenynghe, Saintedym Wills, et al.
Blood Advances|January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPsJoseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Vaccine|July 7, 2021
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest periodYunda Huang, Kelly E Seaton, Martin Casapia, et al.
Pageof 53